Familial Amyloid Polyneuropathy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IONS | F | Ionis Pharmaceuticals, Inc. | 0.21 | |
BBIO | F | BridgeBio Pharma, Inc. | 0.77 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Familial Amyloid Polyneuropathy stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HRTS | F | Tema Cardiovascular and Metabolic ETF | 6.11 | |
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 3.85 | |
HELX | D | Franklin Genomic Advancements ETF | 2.96 | |
MEDX | F | Horizon Kinetics Medical ETF | 2.78 | |
WDNA | F | WisdomTree BioRevolution Fund | 2.68 |
Compare ETFs
Related Industries:
Biotechnology
- Familial Amyloid Polyneuropathy
Familial amyloid polyneuropathy (FAP), also called transthyretin-related hereditary amyloidosis, transthyretin amyloidosis abbreviated also as ATTR (hereditary form), or Corino de Andrade's disease, is an autosomal dominant neurodegenerative disease. It is a form of amyloidosis, and was first identified and described by Portuguese neurologist Mário Corino da Costa Andrade, in 1952. FAP is distinct from senile systemic amyloidosis (SSA), which is not inherited, and which was determined to be the primary cause of death for 70% of supercentenarians who have been autopsied.FAP can be ameliorated by liver transplantation.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles